The Physiology of Wound Healing by the Medicinal Maggot, Lucilia sericata

Advances in Insect Physiology

Volumn 39, Issue C, 2010, Pages 39-81

  Nigam, Yamni ^a   Dudley, Edward ^b   Bexfield, Alyson ^b   Bond, A Elizabeth ^b   Evans, Julie ^c   James, Jane ^d  

^a SWANSEA UNIVERSITY   (United Kingdom)

^b SWANSEA UNIVERSITY   (United Kingdom)

^c MORRISTON HOSPITAL   (United Kingdom)

^d WEST WALES GENERAL HOSPITAL   (United Kingdom)

Author keywords

Antibacterial factors; Debridement; Larval therapy; Lucilia sericata; Maggot therapy; Medicinal maggot; Wound healing

Indexed keywords

EID: 77957937829     PISSN: 00652806     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-12-381387-9.00002-6     Document Type: Book

References (130)

1. Abe M., Kurosawa M., Ishikawa O., Miyachi Y. Effect of mast cell derived mediators and mast cell-related neutral proteases on human dermal fibroblast proliferation and type I collagen production. J. Allergy Clin. Immunol. 2000, 106:S78-S84.
2. Altincicek B., Vilcinskas A. Septic injury-inducible genes in medicinal maggots of the green blow fly Lucilia sericata. Insect Mol. Biol. 2009, 18:119-125.
3. Andersen A.S., Joergensen B., Bjarnsholt T., Johansen H., Karlsmark T., Givskov M., Krogfelt K.A. Quorum-sensing-regulated virulence factors in Pseudomonas aeruginosa are toxic to Lucilia sericata maggots. Microbiology 2010, 156:400-407.
4. Anderson G. Insect succession on carrion and its relationship to determining time of death. Forensic Entomology: The Utility of Arthropods in Legal Investigations 2001, 143-177. CRC Press, Boca Raton. J.H. Byrd, J.L. Castner (Eds.).
5. Armstrong D.G., Salas P., Short B., Martin B.R., Kimbriel H.R., Nixon B.P., Boulton A.J. Maggot therapy in "lower-extremity hospice" wound care: fewer amputations and more antibiotic-free days. J. Am. Podiatr. Med. Assoc. 2005, 95:254-257.
6. Ashworth J.R., Wall R. Responses of the sheep blowflies Lucilia sericata and L. cuprina to odour and the development of semiochemical baits. Med. Vet. Entomol. 1994, 8:303-309.
7. Baer W.S. The treatment of chronic osteomyelitis with the maggot (larva of the blow fly). J. Bone Joint Surg. 1931, 13:438-475.
8. Barnard D.R. Skeletal-muscular mechanisms of the larva of Lucilia sericata (Meigen) in relation to feeding habit. Pan-Pac. Entomol. 1977, 53:223-229.
9. Barnes K.M., Gennard D.E., Dixon R.A. An assessment of the antibacterial activity in larval excretion/secretion of four species of insects recorded in association with corpses, using Lucilia sericata Meigen as the marker species. Bull. Entomol. Res. 2010, 10.1017/S000748530999071X.
10. Bexfield A., Nigam Y., Thomas S., Ratcliffe N.A. Detection and partial characterisation of two antibacterial factors from the excretions/secretions of the medicinal maggot Lucilia sericata and their activity against methicillin-resistant Staphylococcus aureus (MRSA). Microbes Infect. 2004, 6:1297-1304.
11. Bexfield A., Bond A.E., Roberts E.C., Dudley E., Nigam Y., Thomas S., Newton R.P., Ratcliffe N.A. The antibacterial activity against MRSA strains and other bacteria of a <500Da fraction from maggot excretions/secretions of Lucilia sericata (Diptera: Calliphoridae). Microbes Infect. 2008, 10:325-333.
12. Bexfield A., Bond A.E., Morgan C., Wagstaff J., Newton R.P., Ratcliffe N.A., Dudley E., Nigam Y. Amino acid derivatives from Lucilia sericata excretions/secretions may contribute to the beneficial effects of maggots therapy via increased angiogenesis. Br. J. Dermatol. 2009, 162:554-562.
13. Blair R.J., Meng H., Marchese M.J. Human mast cells stimulate vascular tube formation. Tryptase is a novel, potent angiogenic factor. J. Clin. Invest. 1997, 99:2691-2700.
14. Bowling F.L., Salgami E.V., Boulton A.J.M. Larval therapy: a novel treatment in eliminating methicillin-resistant Staphylococcus aureus from diabetic foot ulcers. Diabetes Care 2007, 30:370-371.
15. Broderick N. Understanding chronic wound healing. Nurs. Pract. 2009, 34:16-22.
16. Acute and Chronic Wounds: Current Management Concepts 2007, Moseby, Missouri. 3rd edn. R.A. Bryant, D.P. Nix (Eds.).
17. Bulet P., Stocklin R. Insect antimicrobial peptides: Structures, properties and gene regulation. Protein Pept. Lett. 2009, 12:3-11.
18. Campobasso C.P., Gherardi M., Caligara M., Sironi L., Introna F. Drug analysis in blowfly larvae and in human tissues: a comparative study. Int. J. Legal Med. 2004, 118:210-214.
19. Cazander G., van Veen K.E., Bouwman L.H., Bernards A.T., Jukema G.N. The influence of maggot excretions on PAO1 biofilm formation on different biomaterials. Clin. Orthop. Relat. Res. 2009, 467:536-545.
20. Cazander G., van de Veerdonk M.C., Vandenbroucke-Grauls C.M., Schreurs M.W., Jukema G.N. Maggot excretions inhibit biofilm formation on biomaterials. Clin. Orthop. Relat. Res. 2010, 10.1007/s11999-010-1309-5.
21. Cerovský V., Zdárek J., Fucík V., Monincová L., Voburka Z., Bém R. Lucifensin, the long-sought antimicrobial factor of medicinal maggots of the blowfly Lucilia sericata. Cell. Mol. Life Sci. 2010, 67:455-466.
22. Chambers L., Woodrow S., Brown A.P., Harris P.D., Phillips D., Hall M., Church J.C.T., Pritchard D.I. Degradation of extracellular matrix components by defined proteases from the greenbottle larva Lucilia sericata used for the clinical debridement of non-healing wounds. Br. J. Dermatol. 2003, 148:14-23.
23. Chan D.C.W., Fong D.H.F., Leung J.Y.Y., Patil N.G., Leung G.K.K. Maggot debridement therapy in chronic wound care. Hong Kong Med. J. 2007, 13:382-386.
24. Chang M.C., Chan C.P., Wu H.L., Chen R.S., Lan W.H., Chen Y.J. Thrombin-stimulated growth, clustering and collagen lattice contraction of human gingival fibroblasts is associated with its protease activity. J. Periodontol. 2001, 72:303-313.
25. Chapman R.F. The Insects: Structure and Function 1998, Cambridge University Press, Cambridge. 2nd edition.
26. Chernin E. Surgical maggots. South Med. J. 1986, 79:1143-1145.
27. Church J.C. The traditional use of maggots in wound healing, and the development of Larva therapy (Bio surgery) in modern medicine. J. Alternative Complement Med. 1996, 2:525-527.
28. Collier R. Medicinal maggots cross border at a crawl. CMAJ 2010, 182:E123-E124.
29. Courtenay M., Church J.C., Ryan T.J. Larva therapy in wound management. J. R. Soc. Med. 2000, 93:72-74.
30. Cruickshank I., Wall R. Population dynamics of the sheep blowfly Lucilia sericata: seasonal patterns and implications for control. J. Appl. Ecol. 2002, 39:493-501.
31. Dadour R., Cook D.F., Fissioli J.N., Bailey W.J. Forensic entomology: application, education and research in Western Australia. Forensic Sci. Int. 2001, 120:48-52.
32. Daeschlein G., Mumcuoglu K.Y., Assadian O., Hoffmeister B., Kramer A. In vitro antibacterial activity of Lucilia sericata maggot secretions. Skin Pharmacol. Physiol. 2007, 20:112-115.
33. Davies L. Observations on the development of Lucilia sericata (Mg.) eggs in sheep fleeces. J. Exp. Biol. 1948, 25:86-102.
34. de la Torre J.I., Chambers J.A. Wound healing, chronic wounds At. http://emedicine.medscape.com/article/1298196-overview.
35. Dossey L. Maggots and leeches: when science and aesthetics collide. Altern. Ther. Health Med. 2002, 8:12-17.
36. Dryburgh N., Smith F., Donaldson J., Mitchell M. Debridement for surgical wounds. Cochrane Database Syst. Rev. 2008, 3:CD006214.
37. Dumville J.C., Worthy G., Bland J.M., Cullum N., Dowson C., Iglesias C.P., Mitchell J.L., Nelson E., Soares M., Torgerson D.J. Larval therapy for leg ulcers (VenUS II): randomised controlled trial. BMJ 2009, 338:1047-1063.
38. Dunbar G. Notes on the Ngemba tribe of the Central Darling River of Western New South Wales. Mankind 1944, 3:140-148.
39. Dunn C., Raghavan U., Pfleiderer A.G. The use of maggots in head and neck necrotizing fasciitis. J. Laryngol. Otol. 2002, 116:70-72.
40. Elkington R.A., Humphries M., Commins M., Maugeri N., Tierney T., Mahony T.J. A Lucilia cuprina excretory-secretory protein inhibits the early phase of lymphocyte activation and subsequent proliferation. Parasite Immunol. 2009, 31:750-765.
41. Erzinclioglu Z. The Biology of Blowflies. Naturalist's Handbook 23: Blowflies 1996, Richmond Publishing, Slough.
42. Fenn-Smith P. Case study: maggot debridement therapy. Wound Pract. Res. 2008, 16:169-170.
43. Fenton A., Wall R., French N. The incidence of sheep strike by Lucilia sericata on sheep farms in Britain: a simulation model. Vet. Parasitol. 1998, 76:211-228.
44. Fine A., Alexander H. Maggot therapy: technique and clinical application. J. Bone Joint Surg. 1934, 16:572-582.
45. Gailit J., Clark R.A.F. Wound repair in the context of the extracellular matrix. Curr. Opin. Cell Biol. 1994, 6:717-725.
46. Gianelli G., Falk-Marzillier J., Schiraldi O. Induction of cell migration by matrix metalloprotease-2 cleavage of laminin-5. Science 1997, 277:225-228.
47. Golinko M.S., Joffe R., Maggi J., Cox D., Chandrasekaran E.B., Tomic-Canic R.M., Brem H. Operative debridement of diabetic foot ulcers. J. Am. Coll. Surg. 2008, 207:E1-E6.
48. Gould L.J., Yager D.R., Cohen I.K., Diegelmann R.F. In vitro analysis of fetal fibroblast collagenolytic activity. Wound Rep. Reg. 1997, 5:151-158.
49. Grassberger M., Reiter C. Effect of temperature on Lucilia sericata (Diptera: Calliphoridae) development with special reference to the isomegalen- and isomorphen-diagram. Forensic Sci. Int. 2001, 120:32-36.
50. Greenberg B. Flies through history. Flies and Disease 1973, Princeton University Press, Princeton. B. Greenberg (Ed.).
51. Greiling D., Clark R.A.F. Fibronectin provides a conduit for fibroblast transmigration from collagenous stroma into fibrin clot provisional matrix. J. Cell Sci. 1997, 110:861-870.
52. Gupta A. A review of the use of maggots in wound therapy. Ann. Plast. Surg. 2008, 60:224-227.
53. Harris L.G., Bexfield A., Nigam Y., Rohde H., Ratcliffe N.A., Mack D. Disruption of Staphylococcus epidermidis biofilms by medicinal maggot Lucilia sericata excretions/secretions. Int. J. Artif. Organs 2009, 32:555-564.
54. Hayes E.J., Wall R., Smith K.E. Mortality rate, reproductive output, and trap response bias in populations of the blowfly Lucilia sericata. Ecol. Entomol. 1999, 24:300-307.
55. Horobin A.J., Shakesheff K.M., Woodrow S., Robinson C., Pritchard D.I. Maggots and wound healing: an investigation of the effects of secretions from Lucilia sericata larvae upon interactions between human dermal fibroblasts and extracellular matrix components. Br. J. Dermatol. 2003, 148:923-933.
56. Horobin A.J., Shakesheff K.M., Pritchard D.I. Maggots and wound healing: an investigation of the effects of secretions from Lucilia sericata larvae upon the migration of human dermal fibroblasts over a fibronectin-coated surface. Wound Rep. Reg. 2005, 13:422-433.
57. Horobin A.J., Shakesheff K.M., Pritchard D.I. Promotion of human dermal fibroblast migration, matrix remodelling and modification of fibroblast morphology within a novel 3D model by Lucilia sericata larval secretions. J. Invest. Dermatol. 2006, 126:1410-1418.
58. Horn K.L., Cobb A.H., Gates G.A. Maggot therapy for subacute mastoiditis. Arch. Otolaryngol 1976, 102:377-379.
59. Huberman L., Gollop N., Mumcuoglu K.Y., Block C., Galun R. Antibacterial properties of whole body extracts and haemolymph of Lucilia sericata maggots. J. Wound Care 2007, 16:123-127.
60. Huberman L., Gollop N., Mumcuoglu K.Y., Breuer E., Bhusare S.R., Shai Y., Galun R. Antibacterial substances of low molecular weight isolated from the blowfly, Lucilia sericata. Med. Vet. Entomol. 2007, 21:127-131.
61. Jaklič D., Lapanje A., Zupančič K., Smrke D., Gunde-Cimerman N. Selective antimicrobial activity of maggots against pathogenic bacteria. J. Med. Microbiol. 2008, 57:617-625.
62. Kerridge A., Lappin-Scott H., Stevens J.R. Antibacterial properties of larval secretions of the blowfly, Lucilia sericata. Med. Vet. Entomol. 2005, 19:333-337.
63. Larrey D.J., Rivinus E.F. Observations on Wounds, and Their Complications by Erysipelas, Gangrene and Tetanus and on the Principal Diseases and Injuries of the Head, Ear and Eye 1832, Key, Mielke and Biddle, Philadelphia.
64. Livingston S.K. The therapeutic active principle of maggots with a description of its clinical application in 567 cases. J. Bone Joint Surg. 1936, 18:751-756.
65. Marriage R. Maggot therapy: past, present and future. The Link 2006, 20-29.
66. Martin D.E., Reece M.C., Maher J.E., Reese A.C. Tissue debris at injury site coated by plasma fibronectin and subsequently removed by tissue macrophages. Arch. Dermatol. 1988, 124:226-229.
67. Messer F.C., McClellan R. Surgical maggots. A study of their functions in wound healing. J. Lab. Clin. Med. 1935, 20:1219-1226.
68. Mumcuoglu K.Y., Ingber A., Gilead L., Stessman J., Friedman R., Schulman H. Maggot therapy for the treatment of intractable wounds. Int. J. Dermatol. 1999, 38:623-627.
69. Namias N., Varela J.E., Varas R.P., Quintana O., Ward C.G. Biodebridement: a case report of maggot therapy for limb salvage after fourth-degree burns. J. Burn Care Rehab. 2000, 21:254-257.
70. Nigam Y., Bexfield A., Thomas S., Ratcliffe N.A. Maggot therapy: the science and implication for CAM part I-history and bacterial resistance. eCAM 2006, 3:223-227.
71. Nordström A., Hansson C., Karlström L. Larval therapy as a palliative treatment for severe arteriosclerotic gangrene on the feet. Clin. Exp. Dermatol. 2009, 34:e683-e685.
72. Orkiszewski K., Madej J., Kilian T. The use of maggot therapy as an adjunct to surgical debridement: a paediatric case report 2006, http://www.worldwidewounds.com/2006/march/orkiszewski/maggot-therapy-paediatric-surgery.html.
73. Pálošová Z., Takáč P., Šrobárová A. 2008, 715-718.
74. Pare A., Johnson T., Spiegel A. The Works of that Famous Chirurgeon Ambrose Pare 1678, Printed by Mary Clarke, London.
75. Pavillard E.R., Wright E.A. An antibiotic from maggots. Nature 1957, 180:916-917.
76. Pečivová J., Mačičková T., Takáč P., Kovacsova M., Cupanikova D., Kozanek M. Effect of the extract from salivary glands of Lucilia sericata on human neutrophils. Neuroendocrinol. Lett. 2008, 29:794-797.
77. Petherick E.S., O'Meara S., Spilsbury K., Iglesias C.P., Nelson E.A., Torgerson D.J. Patient acceptability of larval therapy for leg ulcer treatment: a randomised survey to inform the sample size calculation of a randomised trial. BMC Med. Res. Methodol. 2006, 6:e1-e4.
78. Postlethwaite A.E., Keski-Oja J., Balian G., Kang A.H. Induction of fibroblast chemotaxis by fibronectin: localization of the chemotactic region to a 140, 000-molecular weight non-gelatin-binding fragment. J. Exp. Med. 1981, 153:494-499.
79. Prete P.E. Growth effects of Phaenicia sericata larval extracts on fibroblasts: mechanism for wound healing by maggot therapy. Life Sci. 1997, 60:505-510.
80. Ramundo J.M. Wound debridement. Acute and Chronic Current Management Concepts 2007, 176-192. Mosby Inc., USA. R.A. Bryant, D.P. Nix (Eds.).
81. Reames M.K., Christensen C., Luce E.A. The use of maggots in wound debridement. Ann. Plast. Surg. 1988, 21:388-391.
82. Robinson W. Stimulation of healing in non-healing wounds by allantoin in maggot secretions and of wide biological distribution. J. Bone Joint Surg. 1935, 17:267-271.
83. Robinson W. Ammonium bicarbonate secreted by surgical maggots stimulates healing in purulent wounds. Am. J. Surg. 1940, 47:111-115.
84. Robinson W., Baker F.C. The enzyme urease and the occurrence of ammonia in maggot-infected wounds. J. Parasitol. 1939, 25:149-155.
85. Robinson W., Norwood V.H. The role of surgical maggots in the disinfection of osteomyelitis and other infected wounds. J. Bone Joint Sur. 1933, 15:409-412.
86. Savla U., Appel A.J., Sporn P.H., Waters C.M. Prostaglandin E (2) regulates wound closure in airway epithelium. Am. J. Physiol-Lung Cell. Mol. Phys. 2001, 280:421-431.
87. Schultz G.S., Sibbald R.G.F., Alanga V., Ayello E.A., Dowsett C., Harding K. Wound bed preparation: a systematic approach to wound management. Wound Rep. Reg. 2003, 11:1-28.
88. Schultz G.S., Ladwig G., Wysocki A. Extracellular matrix: review of its roles in acute and chronic wounds At. http://www.worldwidewounds.com/2005/august/Schultz/Extrace-Matric-Acute-Chronic-Wounds.html.
89. Sherman R.A. Maggot debridement in modern medicine. Infect Med. 1998, 15:651-656.
90. Sherman R.A. Maggot versus conservative debridement therapy for the treatment of pressure ulcers. Wound Rep. Reg. 2002, 10:208-214.
91. Sherman R.A. Maggot therapy for treating diabetic foot ulcers unresponsive to conventional therapy. Diabetes Care 2003, 26:446-451.
92. Sherman R.A. Age-old therapy gets new approval. Adv. Skin Wound Care 2005, 18:12-15.
93. Sherman R.A. Maggot therapy takes us back to the future of wound care: new and improved maggot therapy for the 21st century. J. Diabetes Sci. Technol. 2009, 3:336-344.
94. Sherman R.A., Mumcuoglu K.Y. Maggot therapy: apparently a good treatment despite poor study and inadequate analysis. BMJ Rapid Resp. 2009, At. http://www.bmj.com/cgi/eletters/338/mar19_2/b773.
95. Sherman R.A., Wyle F.A., Vulpe M., Wishnow R., Lturrino J. Maggot therapy for treating pressure sores in spinal cord patients. J. Am. Paraplegia Soc. 1991, 14:200.
96. Sherman R.A., Wyle F.A., Vulpe M., Levsen L., Castillo L. The utility of maggot therapy for treating pressure sores. J. Am. Paraplegia Soc. 1993, 16:269.
97. Sherman R.A., Wyle F., Vulpe M. Maggot debridement therapy for treating pressure ulcers in spinal cord injury patients. J. Spinal Cord Med. 1995, 18:71-74.
98. Sherman R.A., Tran J.M.T., Sullivan R. Maggot therapy for venous stasis ulcers. Arch. Dermatol. 1996, 132:254-256.
99. Sherman R.A., Sherman J., Gilead L., Lipo M., Mumcuoglu K.Y. Maggot débridement therapy in outpatients. Arch. Phys. Med. Rehabil. 2001, 82:1226-1229.
100. Simmons S. A bacteriocidal principle in excretions surgical maggots which destroys important etiological agents of pyrogenic infections. J. Bacteriol. 1935, 30:253-267.
101. Simmons S. The bactericidal properties of excretions of the maggot of Lucilia sericata. Bull. Entomol. Res. 1935, 26:559-563.
102. Smith A.G., Powis R.A., Pritchard D.I., Britland S.T. Greenbottle (Lucilia sericata) larval secretions delivered from a prototype hydrogel wound dressing accelerate the closure of model wounds. Biotech. Progress 2006, 22:1690-1696.
103. Smith K.G.V. A Manual of Forensic Entomology 1986, Cornell University Press, Ithaca, New York.
104. Snyder R.J. Maggot therapy in clinical practice. Podiatr. Manag. 2009, 135-138.
105. Spilsbury K., Cullum N., Dumville J., O'Meara S., Petherick E., Thompson C. Exploring patient perceptions of larval therapy as a potential treatment for venous leg ulceration. Health Expect. 2008, 11:148-159.
106. Steenvoorde P., Jacobi C., Wong C., Jukema G. Maggot debridement therapy in necrotizing fasciitis. Methods Wounds 2007, 19:73-78.
107. Stevens J., Wall R. Classification of the genus Lucilia (Diptera: Calliphoridae): a preliminary parsimony analysis. J. Nat. Hist. 1996, 30:1087-1094.
108. Stevens J., Wall R. Genetic variation in populations of the blowflies Lucilia cuprina and Lucilia sericata (Diptera: Calliphoridae). Random amplified polymorphic DNA analysis and mitochondrial DNA sequences biochemical. Syst. Ecol. 1997, 25:81-97.
109. Tantawi T.I., Gohar Y.M., Kotb M.M., Beshara F.M., El-Naggar M.M. Clinical and microbiological efficacy of MDT in the treatment of diabetic foot ulcers. J. Wound Care 2007, 16:379-383.
110. Telford G., Brown A.P., Seabra R.A.M., Horobin A.J., Rich A., English J.S.C., Pritchard D.I. Degradation of eschar from vemous leg ulcers using a recombinant chymotrypsin from Lucilia sericata. Br. J. Dermatol. 2010, 10.1111/j.1365-2133.2010.09854.x.
111. Terra W.R., Ferreira C. Insect digestive enzymes: properties compartmentalization and function. Comp. Biochem. Physiol. B 1994, 109:1-62.
112. Thomas S., Jones M., Shutler S., Jones S. Using larvae in modern wound management. J. Wound Care 1996, 5:60-69.
113. Trengrove N.J., Stacey M.J., Macauley S., Bennett N., Gibson J., Burslem F., Murphy G., Schultz G. Analysis of the acute and chronic wound environments: the role of proteases and their inhibitors. Wound Rep. Reg. 1999, 7:442-452.
114. Utz E.R., Elster E.A., Tadaki D.K., Gage F., Perdue P.W., Forsberg J.A., Stojadinovic A., Hawksworth J.S., Brown T.S. Metalloproteinase expression is associated with traumatic wound failure. J. Surg. Res. 2010, 159:633-639.
115. van der Plas M.J.A., ven der Does A.M., Baldry M., Dogterom-Ballering H.C.M., van Gulpen C., van Dissel J.T., Nibbering P.H., Jukema G.N. Maggot excretions/secretions inhibit multiple neutrophil pro-inflammatory responses. Microbes Infect. 2007, 9:507-514.
116. van der Plas M.J., Jukema G.N., Wai S.W., Dogterom-Ballering H.C., Lagendijk E.L., van Gulpen C., van Dissel J.T., Bloemberg G.V., Nibbering P.H. Maggot excretions/secretions are differentially effective against biofilms of Staphylococcus aureus and Pseudomonas aeruginosa. J. Antimicrob. Chemother. 2008, 61:117-122.
117. van der Plas M.J.A., Baldry M., Van Dissel J.T., Jukema G.N., Nibbering P.H. Maggot secretions suppress pro-inflammatory responses of human monocytes through elevation of cyclic AMP. Diabetologia 2009, 52:1962-1970.
118. van der Plas M.J.A., van Dissel J.T., Nibbering P.H. Maggot secretions skew monocyte-macrophage differentiation away from a pro-inflammatory to a pro-angiogenic type. PLoS ONE 2009, 4:e8071.
119. van der Plas M.J., Dambrot C., Dogterom-Ballering H.C., Kruithof S., van Dissel J.T., Nibbering P.H. Combinations of maggot excretions/secretions and antibiotics are effective against Staphylococcus aureus biofilms and the bacteria derived therefrom. J. Antimicrob. Chemother. 2010, 65:917-923.
120. Vistnes L., Lee R., Ksander A. Proteolytic activity of blowfly larvae secretions in experimental burns. Surgery 1981, 90:835-841.
121. Waltz D.A., Sailor L.Z., Chapman H.A. Cytokines induce urokinase dependent adhesion of human myeloid cells. J. Clin. Invest. 1993, 91:1541-1552.
122. Wang S., Wang K., Xin Y., Lu D. Maggot excretions/secretions induces human microvascular endothelial cell migration through AKT1. Mol. Biol. Rep. 2009, 10.1007/s11033-009-9806-x.
123. Wayman J., Nirojugi V., Walker A., Sowinski A., Walker M. The cost effectiveness of larval therapy in venous ulcers. J. Tissue viability 2000, 10:91-94.
124. Weil G.C., Simon R.J., Sweadner W.R. A biological bacteriological and clinical study of larval or maggot therapy in the treatment of acute and chronic pyogenic infections. Am. J. Surg. 1933, 19:36-48.
125. Whitaker I.S., Twine C., Whitaker M.J., Welck M., Brown C.S., Shandall A. Larval therapy from antiquity to the present day: mechanisms of action, clinical applications and future potential. Postgrad. Med. J. 2007, 83:409-413.
126. Wollina U., Liebold K., Schmidt W.-D., Hartmann M., Fassler D. Biosurgery supports granulation and debridement in chronic wounds -clinical data and remittance spectroscopy measurement. Int. J. Dermatol. 2002, 41:635-639.
127. Wu S.C. Taking a closer look at the impact of wound bioburden. Podiatry Today 2010, 23:36-42.
128. Zhang Z., Wang S., Diao Y., Zhang J., Lv D. Fatty acid extracts from Lucilia sericata larvae promote murine cutaneous wound healing by angiogenic activity. Lipids Health Dis. 2010, 9:24.
129. Ziffren S.E., Heist H.E., May S.C., Womack N.A. The secretion of collagenase by maggots and its implication. Ann. Surg. 1953, 138:932-934.
130. Zumpt F. Myiasis in Man and Animals in the Old World 1965, Butterworths, London.